An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles

Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment

(2019) James Lomas   VALUE IN HEALTH

Public sector financial support for late stage discovery of new drugs in the United States: cohort study

(2019) Rahul K Nayak et al.   BMJ-British Medical Journal

Health Care Spending in the United States and Other High-Income Countries

(2018) Irene Papanicolas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The removal of DAA restrictions in Europe – one step closer to eliminating HCV as a major public health threat

(2018) Alison D. Marshall et al.   JOURNAL OF HEPATOLOGY

New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations

(2017) Takeru Shiroiwa et al.   HEALTH POLICY

Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan

(2017) Takeru Shiroiwa et al.   VALUE IN HEALTH

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

(2015) Karl Claxton et al.   HEALTH TECHNOLOGY ASSESSMENT

Health Utility Scores in Alzheimer’s Disease: Differences Based on Calculation With American and Canadian Preference Weights

(2014) Mark Oremus et al.   VALUE IN HEALTH

The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004

(2008) Anthony H. Harris et al.   MEDICAL DECISION MAKING